CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.
The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.
Kansas City pharmacists walked off the job last September to protest working conditions and brought widespread attention to ...
CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback